Will feds re­clas­si­fy 'mag­ic mush­room' ther­a­pies? Seat­tle doc­tor ramps up court bat­tle

As psy­che­del­ic ther­a­pies make their way through the clin­ic, one Seat­tle doc­tor is tak­ing his fight to change psilo­cy­bin’s sta­tus as a Sched­ule I sub­stance to fed­er­al court.

Sunil Ag­gar­w­al pe­ti­tioned the Ninth Cir­cuit Court of Ap­peals on Thurs­day to re­view a de­ci­sion by the Drug En­force­ment Ad­min­is­tra­tion in Sep­tem­ber to leave psilo­cy­bin on the Sched­ule I list un­der the Con­trolled Sub­stances Act. Sched­ule I drugs are con­sid­ered to have a “high po­ten­tial for abuse” with “no cur­rent­ly ac­cept­ed med­ical use in treat­ment in the Unit­ed States,” ac­cord­ing to the CSA’s lan­guage.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER